VitMode

Rhodiola for Fatigue and Stress

Chronic stress-related fatigue and professional burnout are among the most common reasons patients see a psychiatrist today, and rhodiola is one of the few adaptogens with studies specifically designed around this particular problem — not general "stress resistance," but measurable mental fatigue. We check what these studies actually show, where the evidence ends and overinterpretation begins, and for whom rhodiola may be a real element of support rather than a substitute for treatment.

MWdr Marek WójcikSeptember 10, 202614 min read
Table of contents

Stress-Related Fatigue Isn't the Same as Ordinary Fatigue

In a psychiatric practice, patients regularly present with one seemingly simple complaint: "I'm constantly tired." The problem is that this same word hides several entirely different phenomena — sleep deprivation, depression, hypothyroidism, anemia, and, increasingly, a state described in the literature as stress-related fatigue or, in its extreme form, professional burnout. It's this last category that is rhodiola's best-documented area of effect — not fatigue in general, but a specific variant tied to psychological stress.

The basic profile of rhodiola (Rhodiola rosea) — its origin, history of use, and general characterization as an adaptogen — is covered more broadly in our knowledge-base entry on rhodiola. This article deliberately focuses more narrowly: on what clinical studies specifically show regarding mental fatigue, chronic stress, and burnout symptoms, without repeating the plant's general description.

An Important Distinction Up Front

Burnout is a health phenomenon described in the International Classification of Diseases as a syndrome resulting from chronic workplace stress that has not been successfully managed — it isn't a formal diagnosis in the psychiatric sense, but it is a real, measurable clinical state. No supplement, including rhodiola, is a cure for burnout or a substitute for therapy, changing work conditions, or, when needed, psychiatric treatment — at most it can be a supporting element.

An Open-Label Study in Patients with Burnout Symptoms

Multicenter, open-label, exploratory clinical trial with Rhodiola rosea extract in patients suffering from burnout symptoms

Early-stage evidence

Kasper S, Dienel A · Neuropsychiatric Disease and Treatment · 2017

A multicenter, open-label exploratory trial (no placebo group) included 118 men and women aged 30–60 with burnout symptoms, who took 400 mg of standardized rhodiola extract daily for 12 weeks. Most of the assessed indicators — including emotional exhaustion, fatigue, loss of enjoyment in life, and depersonalization — showed significant improvement during the study, with noticeable changes as early as the first week of use. The authors emphasize this was the first clinical trial specifically designed to evaluate rhodiola's effects in patients with burnout symptoms, rather than general fatigue or stress.

View study

This Is Not an RCT — the Lack of a Placebo Group Is a Serious Limitation

The Kasper and Dienel study was open-label and exploratory, with no placebo control group. This means the observed improvement could largely stem from a placebo effect, the natural course of burnout (some people improve over time regardless of intervention), or expectations among participants and researchers who were aware of which product was being given. The results of this study should be treated as a signal worth further, better-controlled research — not as evidence of effectiveness comparable to a randomized trial.

Stronger Evidence: A Randomized Trial on Stress-Related Fatigue

A methodologically much stronger piece of evidence is an earlier, fully randomized, placebo-controlled study by the same research team, which focused more narrowly on stress-related fatigue in working adults — without requiring formal burnout criteria to be met.

A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue

Early-stage evidence

Olsson EM, von Schéele B, Panossian AG · Planta Medica · 2009

A randomized, double-blind, placebo-controlled study included 60 people diagnosed with stress-related fatigue syndrome, who took a standardized SHR-5 rhodiola extract or placebo for 28 days. The rhodiola group showed significant improvement in mental fatigue indicators, morning cortisol response to stress (awakening test), and attention-concentration test results compared with placebo. This is one of the few studies combining an assessment of subjective fatigue symptoms with an objective measure of cognitive function and a biological marker (cortisol).

View study

Two Studies, Two Different Evidentiary Weights, the Same Direction of Result

Early-stage evidence

The fact that a randomized trial (Olsson et al., 28 days, n=60) and a later open-label study in full-blown burnout (Kasper and Dienel, 12 weeks, n=118) point in the same direction is encouraging — but this convergence shouldn't be mistaken for evidentiary strength comparable to large, multicenter RCTs in pharmacotherapy. Both studies are relatively small, and one had no control group. This remains an early stage (evidenceLevel "early"), not "strong" or even "moderate" evidence in the sense used in evidence-based medicine.

What a Systematic Review Adds

Beyond these two specific studies, it's worth looking at the broader picture. A systematic review by Ishaque and colleagues (2012, BMC Complementary and Alternative Medicine) covered all available clinical studies on rhodiola in the context of physical and mental fatigue and described the evidence as promising but methodologically heterogeneous — different extracts, different doses, different study populations, and different measurement tools make it hard to draw one consistent recommendation on dosing or duration of use.

This pattern — a promising direction of results alongside a small number and heterogeneity of primary studies — is typical of most plant adaptogens, not just rhodiola, and doesn't by itself disqualify the substance. It does mean, however, that the enthusiastic descriptions of "proven" effects on fatigue found in marketing materials outpace the current state of scientific knowledge.

Mechanism — Why Rhodiola Would Affect Stress-Related Fatigue Specifically

The leading hypothesis links rhodiola's effects to modulation of the hypothalamic-pituitary-adrenal (HPA) axis — the system responsible for cortisol release in response to stressors. In the Olsson et al. study, rhodiola supplementation was associated with reduced morning cortisol reactivity, consistent with the hypothesis of a milder, less exhausting stress response, though the study doesn't fully explain the molecular mechanism behind this change.

At the level of active compounds, rhodiola's effects are attributed mainly to salidroside and rosavin. Salidroside is studied for its effect on the availability of serotonin, dopamine, and noradrenaline in preclinical studies (in vitro and in animals) — neurotransmitters heavily involved in regulating mood, motivation, and perceived mental fatigue. It's worth emphasizing, though, that most of this mechanistic data comes from animal models rather than direct human studies, so a 1:1 translation to humans remains a hypothesis, not an established fact.

Check your profile

Constantly feeling tired?

Before reaching for random supplements, find out what's likely to matter most in your case. Answer a few questions about sleep, diet, stress, and lifestyle.

Takes about 2 minutesBased on scientific evidence

Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.

Myth vs. Fact: Is Rhodiola a Substitute for Burnout Treatment?

Myth

Since a clinical study showed improvement in burnout symptoms after rhodiola, it can be used instead of therapy, changing work conditions, or a psychiatric consultation.

Fact

The Kasper and Dienel study evaluated rhodiola as a standalone intervention in people with burnout symptoms, but it was open-label, without a control group, and didn't compare it against established treatment methods such as psychotherapy or reducing workload. Burnout is a multidimensional phenomenon that often requires a systemic intervention (changing work conditions, psychological support), not only a pharmacological or supplement-based one. Treating rhodiola as a standalone "cure for burnout" would be an overinterpretation of the available data.

Who Rhodiola Makes Sense For, and Who Should Avoid It

Who Might Consider Rhodiola as a Supporting Element

  • People with mild to moderate, chronic mental fatigue related to work or everyday stress, without a diagnosed depression or another disorder requiring treatment
  • People looking for gentle daytime support, without the strong stimulant effect typical of caffeine
  • People whose doctor or psychotherapist is already addressing the main source of stress, where rhodiola would only be an additional, non-pharmacological element of support

Who Should Take Particular Caution

People with bipolar disorder should avoid rhodiola without a psychiatric consultation — there is a theoretical risk, described in the literature, of triggering a manic episode with substances that stimulate monoaminergic neurotransmission. People taking antidepressants, especially SSRIs or MAO inhibitors, should consult a doctor before starting supplementation due to a theoretical risk of serotonergic interactions. Symptoms suggesting full-blown depression (persistent sadness, anhedonia, thoughts of hopelessness) require psychiatric evaluation and shouldn't be self-treated with a supplement — rhodiola is not an antidepressant nor a substitute for one.

Limitations of the Available Data

QuestionShort Answer
Does rhodiola help with stress-related fatigue?Early evidence from one RCT (n=60, 28 days) and one open-label study (n=118, 12 weeks) points to improvement, but the samples are small
Is it a cure for professional burnout?No — there are no studies comparing rhodiola with established burnout treatments; treat it as a possible supporting element, not a substitute for therapy
How fast is an effect seen?In the RCT, improvement was visible after 28 days; in the open-label study, some changes were reported as early as the first week
Is it safe for everyone?No — caution is warranted with bipolar disorder and concurrent use of antidepressants
Does it replace depression treatment?No — symptoms suggesting depression require psychiatric evaluation and treatment, not self-supplementation

Rhodiola and Stress-Related Fatigue at a Glance

Our Editorial Recommendation

Rhodiola is among the few adaptogens with a study specifically designed around stress-related fatigue, rather than just a general marketing claim of "reduces stress." That's a real advantage over many competing products in this category. At the same time, the scale and methodological quality of the available studies — a small RCT sample, no control group in the burnout study — don't yet allow rhodiola to be described as a confirmed, powerful therapeutic intervention, but rather as a promising element worth considering as part of a broader approach to chronic fatigue.

In clinical practice, rhodiola most often appears helpful as one piece of the puzzle for patients who are simultaneously working on the source of their stress — not as a standalone solution replacing that work. If fatigue persists despite attempts at self-management, is severe, or is accompanied by mood symptoms, it's worth not delaying a consultation rather than seeking a solution in supplementation alone.

Rhodiola isn't a cure for burnout — at best it's one of the tools that can ease symptoms while the patient and their doctor address the actual cause. Treating a supplement as a substitute for that work is the most common mistake I see in practice.

Dr. Marek Wójcik, VitMode editorial team

Frequently asked questions

Stress-related fatigue is a specific pattern of mental fatigue tied to chronic stress, assessed in studies with specific scales and, in the case of the Olsson et al. study, also a biological marker (morning cortisol). It's a narrower category than general "fatigue," which can have many other causes, such as sleep deprivation, hypothyroidism, or depression — and which requires different diagnostic workup.

The only available study in this specific population (Kasper and Dienel, 2017) was open-label, without a placebo group, so the observed improvement could partly stem from a placebo effect or the natural course of symptoms. The result is promising and worth further research, but it doesn't yet constitute strong evidence of effectiveness.

In the randomized study (Olsson et al.), improvement was observed after 28 days of regular use. In the open-label study on burnout symptoms, some indicators improved as early as the first week, though the full effect was assessed at 12 weeks.

This requires consulting your treating physician. There is a theoretical risk of serotonergic interactions when combining rhodiola with SSRIs or MAO inhibitors — the decision about any combination should be made by a doctor familiar with the patient's full clinical picture.

Caution is advised — the literature describes a theoretical risk of triggering a manic episode when using substances that stimulate monoaminergic neurotransmission, a category that includes rhodiola. People with this diagnosis should consult a psychiatrist about supplementation before starting.

No — unlike classic stimulants, rhodiola typically doesn't produce an immediate, strong stimulating effect. The available studies evaluated its effect after at least several weeks of regular use, not after a single dose.

This isn't recommended. Burnout and chronic fatigue can have complex causes, including co-occurring depression or other disorders requiring proper diagnosis and treatment. Given the current state of evidence, rhodiola can at most be an additional element of support, not a substitute for a medical consultation or psychotherapy, especially when symptoms are severe or long-lasting.

Sources

MW

dr Marek Wójcik

Specialist physician in psychiatry, mental-health & sleep consultant

Marek specializes in psychiatry and spent most of his career at the intersection of psychiatry and sleep medicine, watching how often mood disorders and sleep problems feed each other — and how treating them separately tends to work worse than treating them together. Julia talked him into joining, having met him while both were working on the topic of insomnia: him from the clinical side, her from chronobiology. He reviews content on how supplements and lifestyle affect mood, stress and cognitive function, always underlining the difference between easing a symptom and treating its cause, and flagging when a topic goes beyond what's safe to handle on your own. He believes the biggest risk in popular mental-health content isn't too little information but too much of it with no sense of priority — and that's the hierarchy he tries to bring to his reviews.

Related articles

Zmęczony mężczyzna ziewający, ręka na ustach

Testosterone and Fatigue — Can Low Testosterone Really Drain Your Energy?

Fatigue makes every list of low-testosterone symptoms, and TRT is sometimes marketed as a cure for low energy. The largest study ever to test this directly showed something different — and it's worth knowing before you go looking for the cause of your fatigue in your hormones.

11 min

August 15, 2026

Osoba w spokojnej pozycji medytacyjnej, dłoń spoczywająca na kolanie podczas ćwiczenia oddechowego

HRV Training and Resonance Breathing: Does It Really Reduce Stress?

Your watch shows your HRV, but the measurement itself changes nothing. HRV training (biofeedback) is a specific technique — breathing at a resonance rate, usually around 6 breaths per minute — with real scientific support for reducing stress and anxiety. Here's how it works and how to start.

10 min

August 22, 2026

Widok z góry na złotą łyżkę z kapsułkami i proszkiem suplementów na zielonym tle

Ashwagandha and Cortisol: Does This Adaptogen Really Lower Stress?

"Ashwagandha lowers cortisol" is one of the most repeated claims in the world of adaptogens — and, rarely for this kind of claim, one actually backed by solid numbers from meta-analyses. But the newest, largest meta-analysis to date, from 2025, shows something that changes how this effect should be understood: a drop in blood cortisol and a subjective feeling of reduced stress turn out to be two separate, not always linked, stories.

12 min

August 24, 2026

Filiżanka herbaty i książka na tarasie sprzyjającym relaksowi

L-theanine, Stress, and Anxiety — What Does a Clinical Trial Actually Show?

L-theanine, an amino acid best known as a mellowing companion to caffeine, is increasingly marketed on its own as a natural way to cope with stress and anxiety. A randomized, double-blind trial using magnetoencephalography (MEG) did find measurable changes in stress response and brain activity — but it's worth understanding exactly what was measured, in whom, and what these results do not prove about clinical anxiety disorder.

11 min

August 27, 2026

Related knowledge base entries

Comments (2)

  • KW

    Kasia W. 2 weeks ago

    Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.

  • MT

    Marek T. a month ago

    Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.